Cover Image
市場調查報告書

公共醫療機關導向分析·實驗服務的市場:2021年為止的預測

Analytical Laboratory Services Market by Public Health Organization, - by types of services (Stability, Raw Material, Physical Characterization, Method Validation, Microbial Testing, Environmental Monitoring, Bioanalytical Testing) - Forecast to 2021

出版商 MarketsandMarkets 商品編碼 545449
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
公共醫療機關導向分析·實驗服務的市場:2021年為止的預測 Analytical Laboratory Services Market by Public Health Organization, - by types of services (Stability, Raw Material, Physical Characterization, Method Validation, Microbial Testing, Environmental Monitoring, Bioanalytical Testing) - Forecast to 2021
出版日期: 2017年04月17日 內容資訊: 英文 70 Pages
簡介

全球各國公共醫療機關的分析檢驗服務支出額,今後預測將以10.5%的年複合成長率 (CAGR) 擴大,到2021年擴大到33億3800萬美元。市場成長 (支出擴大)的主要原因有隨著公共醫療機關的醫藥品·醫療設備的支出增額,新藥的認證數量·臨床實驗數量的增加,及專門性分析實驗服務的需求等。就領域別來看是生物分析檢驗,就地區別來看則是北美各國佔有最大的市場佔有率。

本報告提供全球各國的公共醫療機關分析檢驗服務的市場收益額 (支出額) 相關分析,提供整體支出額趨勢和預測,主要的推動及阻礙市場要素,檢驗服務的項目詳細趨勢,各地區市場概況·趨勢預測等調查。

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 支出額分析:概要

  • 簡介
  • 主要趨勢
    • 公共組織藥物和醫療設備的支出額增加
    • 加強分析測試能力的政府措施
    • 增加藥物批准和臨床試驗數量
    • 特殊分析檢驗服務的需求增加
  • 課題
    • 複雜且創新的醫藥品需要獨特的分析檢驗方法
  • 結論

第5章 公共機關的醫療分析檢驗服務的支出額分析:服務類別

  • 簡介
  • 生物分析檢驗
  • 順利地租賃檢驗
  • 穩定性檢驗
  • 原料檢驗
  • 物理特性
  • 檢驗手法的認證
  • 微生物檢驗
  • 環境監測

第6章 地區分析

  • 簡介
  • 北美 (美國,加拿大)
  • 歐洲 (德國,英國,法國,義大利,西班牙等)
  • 亞太地區 (中國,日本,印度等)
  • 其他的國? (RoW:南美,中東·非洲)

第7章 附錄

目錄
Product Code: AST 5171

The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 million by 2021, growing at a CAGR of around 10.5% during the forecast period. Growth in the market can be attributed to a number of factors such as the growing expenditure on drugs and medical devices by public health organizations, increasing number of drug approvals and clinical trials, and rising demand for specialized analytical laboratory services. However, complex and innovative pharmaceutical products requiring a distinctive analytical testing approach is the major challenge hampering the growth of government support.

The analytical laboratory services market, by public health organization in this report is segmented by service type. In 2015, the bioanalytical testing segment accounted for the largest share of the analytical laboratory services market, by public health organization. This growth can be attributed to factors such as the usage and development of a large number of macromolecules and biosimilars for various therapeutic areas and the growing biopharmaceutical industry across the globe. The batch release testing services segment has the second largest share during the forecast period. The growth can be attributed to the need for checking and validating the process for product development among pharmaceutical & biopharmaceutical companies and the increasing usage of dissolution test in the development and approval of generic solid oral dosage forms.

In 2015, North America accounted for the largest share in the global analytical laboratory services market, by public health organization, followed by Europe, Asia-Pacific, and the RoW. Growth in the North American region is largely driven by the high expenditure on quality testing, strong regulatory scenario, increasing number of clinical trials, and the well-established federal testing laboratories in the region. Asia-Pacific is expected to grow at a higher CAGR during the forecast period as compared to North America and Europe. This can be attributed to the fast-growing pharmaceutical industry in this region, increased government expenditure on healthcare, increasing number of highly competitive and extremely fragmented pharmaceutical companies, and increased spending by governments to set up new laboratories in Asian countries.

The major public health organizations, in analytical laboratory services market, include the Food and Drug Administration (U.S.), European Medicines Agency (U.K.), Federal Institute for Drugs and Medical Devices (Germany), Agence francaise de securite sanitaire des produits de sante (France), Agenzia Italiana del Farmaco (Italy), the Spanish Medicines and Health Products Agency (Spain), Central Drugs Standard Control Organization (India), China Food and Drug Administration, and Pharmaceuticals and Medical Devices Agency (Japan).

Research Coverage:

  • Detailed insights on all analytical laboratory services, based on service type (bioanalytical testing, batch release testing, stability testing, raw material testing, physical characterization, method validation, microbial testing, and environmental monitoring). This can help market players to identify key regional public spenders, and high growth segments in the analytical laboratory services market, by public health organization.
  • The report also provides information on key government agencies and their spend assessment. This can help the company to assess the regulatory compliance at global and regional levels in a better manner.
  • Country-wise market size and forecast for all the types of services. Thus, not only the high growth spenders and service areas; the market size numbers provided in the report will also enable market players to identify key geographic markets, and thereby strategize global efforts in order to achieve substantial assistance from public health organizations in the coming years.
  • It provides insights on key trends and challenges faced by the public health organizations on analytical laboratory services market.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the public expenditure based on region, which in turn would help them better understand the analytical laboratory services market, by public health organization. This report gives insight upon the various types of analytical laboratory services.

TABLE OF CONTENTS

1 INTRODUCTION 8

  • 1.1 OBJECTIVES OF THE STUDY 8
  • 1.2 SCOPE OF THE REPORT 8

2 RESEARCH METHODOLOGY 10

  • 2.1 RESEARCH APPROACH 10
    • 2.1.1 SECONDARY DATA 10
    • 2.1.2 PRIMARY DATA 11
      • 2.1.2.1 Breakdown of Primary Interviews 12
      • 2.1.2.2 Key Industry Insights 12
    • 2.1.3 MARKET SIZE ESTIMATION 13

3 EXECUTIVE SUMMARY 15

  • 3.1 HEALTHCARE ANALYTICAL TESTING SERVICES: OVERVIEW 15
  • 3.2 OUTSOURCED HEALTHCARE ANALYTICAL TESTING SERVICES 15
  • 3.3 PUBLIC ORGANIZATION SPENDING ASSESSMENT FOR HEALTHCARE ANALYTICAL TESTING SERVICES 15

4 SPENDING ASSESSMENT OVERVIEW 19

  • 4.1 INTRODUCTION 19
  • 4.2 KEY TRENDS 19
    • 4.2.1 GROWING EXPENDITURE ON DRUGS AND MEDICAL DEVICES BY PUBLIC ORGANIZATIONS 19
    • 4.2.2 GOVERNMENT INITIATIVES TO STRENGTHEN ANALYTICAL TESTING CAPABILITIES 20
    • 4.2.3 INCREASING NUMBER OF DRUG APPROVALS AND CLINICAL TRIALS 21
    • 4.2.4 RISING DEMAND FOR SPECIALIZED ANALYTICAL TESTING SERVICES 22
  • 4.3 CHALLENGES 22
    • 4.3.1 COMPLEX AND INNOVATIVE PHARMACEUTICAL PRODUCTS REQUIRING A DISTINCTIVE ANALYTICAL TESTING APPROACH 22
  • 4.4 CONCLUSION 22

5 PUBLIC ORGANIZATION SPEND ASSESSMENT FOR HEALTHCARE ANALYTICAL TESTING SERVICES: TYPES OF SERVICES 23

  • 5.1 INTRODUCTION 24
  • 5.2 BIOANALYTICAL TESTING 25
  • 5.3 BATCH RELEASE TESTING 27
  • 5.4 STABILITY TESTING 28
  • 5.5 RAW MATERIAL TESTING 29
  • 5.6 PHYSICAL CHARACTERIZATION 30
  • 5.7 METHOD VALIDATION 31
  • 5.8 MICROBIAL TESTING 32
  • 5.9 ENVIRONMENTAL MONITORING 33

6 GEOGRAPHIC ANALYSIS 35

  • 6.1 INTRODUCTION 36
  • 6.2 NORTH AMERICA 37
    • 6.2.1 U.S. 38
    • 6.2.2 CANADA 40
  • 6.3 EUROPE 42
    • 6.3.1 GERMANY 43
    • 6.3.2 U.K. 44
    • 6.3.3 FRANCE 46
    • 6.3.4 ITALY 47
    • 6.3.5 SPAIN 48
    • 6.3.6 REST OF EUROPE 49
  • 6.4 ASIA-PACIFIC (APAC) 51
    • 6.4.1 CHINA 52
    • 6.4.2 JAPAN 54
    • 6.4.3 INDIA 55
    • 6.4.4 REST OF APAC 56
  • 6.5 REST OF THE WORLD (ROW) 58
    • 6.5.1 LATIN AMERICA 59
    • 6.5.2 MIDDLE EAST AND AFRICA 60

7 APPENDIX 62

  • 7.1 INSIGHTS OF KEY EXPERTS 62
  • 7.2 RECENT DEVELOPMENTS 63
  • 7.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 65
  • 7.4 RELATED REPORTS 67
  • 7.5 AUTHOR DETAILS 68

LIST OF TABLES

  • TABLE 1: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY REGION (USD MILLION) 18
  • TABLE 2: FUNDING ON HUMAN DRUGS AND DEVICES BY FDA, 2013-2017 (USD MILLION) 19
  • TABLE 3: BUDGET EXPENDITURE ON EVALUATION OF MEDICINAL PRODUCTS BY EMA, 2013-2015 (USD MILLION) 20
  • TABLE 4: NUMBER OF CLINICAL TRIALS AUTHORIZED BY COMPETENT AUTHORITIES (2011-2014) 21
  • TABLE 5: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 24
  • TABLE 6: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION) 25
  • TABLE 7: GLOBAL SPENDING ON BIOANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION) 26
  • TABLE 8: GLOBAL SPENDING ON BATCH RELEASE TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION) 27
  • TABLE 9: GLOBAL SPENDING ON STABILITY TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION) 28
  • TABLE 10: GLOBAL SPENDING ON RAW MATERIAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION) 29
  • TABLE 11: GLOBAL SPENDING ON PHYSICAL CHARACTERIZATION SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION) 30
  • TABLE 12: GLOBAL SPENDING ON METHOD VALIDATION SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION) 31
  • TABLE 13: GLOBAL SPENDING ON MICROBIAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION) 32
  • TABLE 14: GLOBAL SPENDING ON ENVIRONMENTAL MONITORING SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION) 34
  • TABLE 15: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION) 36
  • TABLE 16: NORTH AMERICA: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY, 2014-2021 (USD MILLION) 37
  • TABLE 17: NORTH AMERICA: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 38
  • TABLE 18: U.S.: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 40
  • TABLE 19: CANADA: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 41
  • TABLE 20: EUROPE: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY, 2014-2021 (USD MILLION) 42
  • TABLE 21: EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 43
  • TABLE 22: GERMANY: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 44
  • TABLE 23: U.K.: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 45
  • TABLE 24: FRANCE: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 47
  • TABLE 25: ITALY: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 48
  • TABLE 26: SPAIN: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 49
  • TABLE 27: ROE: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 50
  • TABLE 28: ASIA-PACIFIC: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY, 2014-2021 (USD MILLION) 51
  • TABLE 29: ASIA-PACIFIC: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 52
  • TABLE 30: CHINA: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 53
  • TABLE 31: JAPAN: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 55
  • TABLE 32: INDIA: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 56
  • TABLE 33: REST OF APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 57
  • TABLE 34: ROW: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY COUNTRY, 2014-2021 (USD MILLION) 58
  • TABLE 35: ROW: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 58
  • TABLE 36: LATIN AMERICA: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 60
  • TABLE 37: MIDDLE EAST AND AFRICA: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS, BY SERVICE TYPE, 2014-2021 (USD MILLION) 61

LIST OF FIGURES

  • FIGURE 1: SECONDARY RESEARCH APPROACH 10
  • FIGURE 2: PRIMARY RESEARCH APPROACH 11
  • FIGURE 3: MARKET SIZING APPROACH 13
  • FIGURE 4: MARKET SIZING METHODOLOGY 14
  • FIGURE 5: BIOANALYTICAL TESTING SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 16
  • FIGURE 6: GEOGRAPHIC SNAPSHOT: SPENDING ON HEALTHCARE ANALYTICAL TESTING SERVICES BY PUBLIC ORGANIZATIONS 17
  • FIGURE 7: FDA BUDGET ON MEDICAL DEVICES AND RADIOLOGICAL HEALTH, 2013-2017 (USD MILLION) 39
Back to Top